Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth Aparajita Dutta 16 hrs ago Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.
Healthcare ETFs Are Looking Up: Here's Why Sanghamitra Saha Aug 19, 2026 Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.